corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 8903

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Stetler CJ.
Manufacturers face health care problems
New Physician 1971 Mar; 20:161-163


Abstract:

U. S. prescription costs for the year 1969 were reviewed, and certain facts about the country’s drug industry presented. The average return on invested capital in the drug industry in 1969 was 18.4%, comparable to that of the soft drink industry, versus 11.2% for all industry. The average drug store prescription in 1969 cost the consumer $3.68, and the average profit for the manufacturer on such a prescription was 18 cents. Per capita expenditures for the year for prescriptions through retail pharmacies—not including drugs administered during hospitalization—were $19.00. Of the more than 1,200 U. S. drug companies, 124 are members of the Pharmaceutical Manufacturers Association and manufacture 95% of the nation’s prescription drugs. Pharmaceutical industry research activities and achievements are briefly discussed.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.